title: Conjugation of squalene to acyclovir improves the affinity for biomembrane models.
abstract: Differential scanning calorimetry was used to study the interaction of acyclovir and its prodrug squalenoyl-acyclovir (obtained by conjugation of 1,1',2-tris-nor-squalene acid (squaleneCOOH) with acyclovir) with biomembrane models made of DMPC multilamellar vesicles with the aim to verify whether a stronger interaction of the prodrug with respect to the free drug can be obtained. Multilamellar vesicles were prepared in the presence of increasing molar fractions of acyclovir, squaleneCOOH or prodrug and the effect of the compounds on the thermotropic behavior of vesicles was researched, revealing no effect of acyclovir but a strong effect of squaleneCOOH and prodrug. To evaluate if acyclovir, squaleneCOOH and prodrug can be absorbed by the biomembrane model, an experiment was carried out in which the considered compounds were left in contact with the biomembrane model and their eventual uptake was evaluated analyzing the effect on the thermotropic behavior of the biomembrane model. A very small uptake was revealed for all the compounds. To check the potential use of liposomes as a delivery system for the prodrug, the biomembrane models were incubated with liposomes loaded with the compounds and the compounds transferring from the loaded liposomes to the unloaded biomembrane model was followed. The results suggest that liposomes could be used to deliver the squalenoyl-acyclovir to the biomembrane model.
authors.affiliation: Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Sarpietro
authors.forename: Dorotea
authors.initials: D
authors.lastname: Micieli
authors.forename: Flavio
authors.initials: F
authors.lastname: Rocco
authors.forename: Maurizio
authors.initials: M
authors.lastname: Ceruti
authors.forename: Francesco
authors.initials: F
authors.lastname: Castelli
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives / Q000737:chemistry* / Q000378:metabolism; D000998:Antiviral Agents / Q000737:chemistry* / Q000378:metabolism; D001692:Biological Transport; D002152:Calorimetry, Differential Scanning; D002626:Chemistry, Pharmaceutical; D004134:Dimyristoylphosphatidylcholine / Q000737:chemistry* / Q000378:metabolism; D008051:Lipid Bilayers / Q000737:chemistry* / Q000378:metabolism; D008081:Liposomes; D008954:Models, Biological; D010539:Permeability; D011355:Prodrugs / Q000737:chemistry* / Q000378:metabolism; D013185:Squalene / Q000031:analogs & derivatives / Q000737:chemistry* / Q000378:metabolism; D013678:Technology, Pharmaceutical / Q000379:methods; D044366:Transition Temperature
chemical_list: D000998:Antiviral Agents; D008051:Lipid Bilayers; D008081:Liposomes; D011355:Prodrugs; D013185:Squalene; D004134:Dimyristoylphosphatidylcholine; D000212:Acyclovir